All posts by imreal

Aesthetics Biomedical® Hires Two New Executives to Join the Company’s Leadership Team to Fuel Growth Trajectory


“I’m honored to be joining an organization about to reignite aesthetics with Vivace Ultra™ and SoME® PRP Skincare,” says Derek Harmon.

Aesthetics Biomedical® Inc. (ABM), in its ongoing efforts to meet the increasing demand for its revolutionary aesthetic products and distribution growth, is continuing to build its executive team recruiting top industry experts Derek Harmon as Vice President of U.S. Sales and Don Selvey, NMD, MS as Vice President of Regulatory respectively. Mr. Harmon and Dr. Selvey will play pivotal roles in the company’s expansion and national distribution of current products including the legacy Vivace® Microneedle RF treatment and device, SoME® PRP Skincare and focus on the new era of energy-based technology with Vivace Ultra™, with expected FDA Clearance, is expected to roll-out via limited commercial release in the fall to top tier plastic surgeons, dermatologists, and medical aesthetic practitioners across the country.

“I’m honored to be joining an organization about to reignite aesthetics with Vivace Ultra™ and SoME® PRP Skincare,” says Derek Harmon. “I’m impressed with what the team has created that uniquely positions ABM as a leader in this industry”, he continued. “After over two decades of experience encompassing a deep understanding of the aesthetics market and the needs of patients and providers alike, I could not be more thrilled to lead U.S. Sales, Practice Development, and Clinical teams to new heights with our portfolio.”

Mr. Harmon brings an award-winning, 20+ year career of industry expertise, results, and leadership to the ABM Executive Team. A seasoned, results-oriented Sales & Marketing Executive with a background focused on aesthetics, medical devices, capital equipment, pharmaceutical and healthcare, Derek most recently served as Director of Surgical Sales at Cynosure. He co-created their surgical division and implemented MyEllevate®, their successful, minimally invasive surgical technology. Prior to Cynosure, Derek was the Director of Business Development for Fresenius Medical Care and responsible for the growth of $400M in treatment revenue, through strategic M&A, joint ventures, and real-estate development of clinics. Derek simultaneously led the company’s telemedicine rollout during the COVID-19 pandemic to keep physicians, clinical teams, and patients safe during an unprecedented time.

Previously, he also spent nearly a decade at Allergan, holding various leadership roles in sales, marketing and practice development, building aesthetic markets for Botox® Cosmetic, Juvederm® XC, Kybella®, Voluma®, Latisse®, and the Allē℠ Patient Loyalty Program. Derek also held positions at Pfizer-Wyeth and Merck & Co. Inc. He currently serves as a Board Member for RealSelf’s Industry Insiders.

Dr. Don Selvey will oversee Regulatory Affairs and Quality Assurance for Aesthetics Biomedical® Inc., bringing a combination of more than 30 years of clinical practice and industry experience in regulatory and clinical activity with medical device and pharmaceutical companies. Dr. Selvey has worked with medical device designers and manufacturers to produce novel devices such as external and implantable drug delivery systems, the original continuous glucose monitoring system, permanently implanted biomaterials for both bone and soft tissues, orthopedic implants and aesthetic dermal fillers and neuromodulators.

“I am very pleased to have joined Aesthetics Biomedical® Inc. working across compliance, quality and regulatory affairs departments for such an exceptional portfolio of advanced devices. With such a strong leadership team, innovative technologies in their Microneedle RadioFrequency device and breadth of practice relationships, I am excited for this next chapter with a company poised for even greater accomplishments and successes ahead.,” says Dr. Selvey.

Aesthetics Biomedical®, led by Founder & Chief Executive Officer, MaryAnn Guerra, achieved its initial success with Vivace® Microneedle RF and Vivace Experience® in the US, the most well-known RF microneedling treatment device in the industry, with exceptional technology and patient outcome. Aesthetics Biomedical® is now poised for industry leadership in the advanced aesthetics space with an expanded, elevated and forward-thinking management team and the latest unique multi-modality device to deliver the most advances in bespoke aesthetics and beauty.

ABOUT AESTHETICS BIOMEDICAL®: Aesthetics Biomedical® Inc., headquartered in Phoenix, Ariz., is committed to the development and distribution of novel aesthetic devices, products, and services in the global market. Aesthetics Biomedical’s innovation center is a leader in breakthrough technologies and combination therapies for its clients, physician network and the aesthetic arena, creating novel patient treatment experiences that benefit from ongoing research, approved clinical indications for use, as well as a personalized approach designed for consumer benefit. For more information, please visit AestheticsBiomedical.com. IG Twitter Linkedin Facebook

Share article on social media or email:



Foreign Material Contamination — Proactive Prevention, Essentials and Improvements, Upcoming Webinar Hosted by Xtalks


Even with increased scrutiny from regulators, customers and manufacturers; foreign material contamination still happens too often.

Xtalks, a leading provider of educational webinars to the global life science, food and medical device community, has partnered with Intertek Alchemy, the global leader in training solutions for the food industry, to host a complimentary webinar on Wednesday, August 17, 2022, at 1pm EDT (10am PDT) titled, Foreign Material Contamination — Proactive Prevention, Essentials and Improvements.

This webinar is in response to many of the largest food recalls being due to foreign material contamination. Even as foreign material detection technology and processes have improved in recent years, foreign material contamination continues to be a major concern.

“Even with increased scrutiny from regulators, customers and manufacturers; foreign material contamination still happens too often. The industry has to maintain vigilance and be continuously improving its systems to help reduce this risk,” says Jeff Chilton, VP Consulting, Intertek Alchemy.

Food industry professionals can join the live webinar with Jeff to review the need for foreign material control to prevent contamination and recalls and see how using a team approach is an effective way to manage the process.

Jeff will also discuss the methods for assessing potential foreign material contamination and the control measures to mitigate foreign material risk.

For more information, or to register for this event, visit Foreign Material Contamination — Proactive Prevention, Essentials and Improvements.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

CareListings now utilized by 15,000+ senior care facilities in the United States


The critical caregiver & nursing shortages in senior care are best addressed by connecting facilities directly with candidates for employment, not by overpaying temporary contractors or staffing agencies.

CareListings, the nation’s largest employment network exclusive to caregivers & nurses in senior care, is now utilized by over 20% of all senior care facilities in the US to source candidates and reach families seeking care. This includes over 15,000 skilled nursing facilities, assisted living homes, home care agencies, and home health & hospice agencies.

“We launched four years ago to provide a better way for families to find senior care options and have now become the most comprehensive resource for caregivers & nurses to find senior care employers. It is a privilege to help so many facilities and caregiver heroes who continue to go above and beyond for our elderly loved ones throughout the covid pandemic,” says the founder and CEO of CareListings, Carl Rogers.

In addition to millions of people using CareListings to explore senior care options annually, thousands of experienced CNA, LPN/LVN, RN, and caregiver job seekers are now signing up every month on CareListings to access employment opportunities in all 50 states.

“The critical caregiver & nursing shortages in senior care are best addressed by connecting facilities directly with candidates for employment, not by overpaying temporary contractors or staffing agencies. With so many facilities struggling financially, it is more important than ever to improve the financial wellbeing of their employees vs paying third-party contractors.”

About CareListings

CareListings is the nation’s most comprehensive resource for families and healthcare professionals exploring senior care options online, with direct contact information for over 150,000 long-term care providers for free – including assisted living homes, home care & home health agencies, skilled nursing facilities, hospices, dialysis facilities, and other types of senior care providers.

Senior care employers hiring nurses and caregivers have the ability to update their business listing information, post job listings, and browse employment profiles for nearby caregiver & nurse job seekers at no cost. CareListings’ optional premium services are subscription-based and allow senior care facilities to reach even more families and source more candidates directly, without referral or placement fees.

Caregivers and nurses exploring nearby job opportunities in senior care can create a centralized profile on the platform and notify hiring managers of their interest in available positions.

CareListings is based in the Ballard neighborhood of Seattle, Washington, and serves families, caregiver job seekers, and senior care employers across the United States. Learn more at carelistings.com.

Share article on social media or email:

The Top 25 Healthcare Technology Leaders of New Jersey for 2022


The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology Leaders of New Jersey for 2022. This list of awardees is comprised of highly adept individuals who have deep experience in the field and have carefully honed their leadership abilities over years in the healthcare technology industry.

Sherine Aly of BioCentric is motivated by her passion for public health and, through her decades of experience, supports her team in their mission to promote optimal patient care through educational services and technology. Tom Xie, Founder, and CEO of CIMS Global, has dedicated his career to research and clinical trial design, data management, and analysis, which has enabled him to stand out as a leader in the industry. And Kevin Ali, CEO of Organon, works together with his team to achieve their mission of delivering impactful medicines and solutions so that women can live healthier lives every day.

These awardees are dedicated to their work and, through their passion, innovation, and expertise, continue to provide the best technology and services to the healthcare industry. Please join us in recognizing The Top 25 Healthcare Technology Leaders of New Jersey for 2022.

Robert Lacaze (Mnemo Therapeutics), Sherine Aly (BioCentric), Brad Schreck (VectraCor), Tom Xie (CIMS Global), Tom Polen (BD), Giovanni Caforio (Bristol Myers Squibb), Ashu Tandon (Syngene International), Kevin Ali (Organon), Chirag Patel (Amneal Pharmaceuticals), Ana Bastiani-Posner (Kyowa Kirin), Manny Soman (Verista), Mark Fleischer (Propel Health), Irene Zhang (Everest Clinical Research), Ken Keller (Daiichi Sankyo), Scott Delaney (Unichem Laboratories Limited), Aki Tomaru (M3 USA), Shannon Campbell (Merus N.V.), Ami Simunovich (BD), Steve Cutler (ICON plc), Bill Hanlon (Labcorp Drug Development), William Compton (Integra LifeSciences), Kirsten Doerfert (Konica Minolta Healthcare Americas), Sheri Lydick (BioAtla), Kelly Ketterson (Genomic Prediction), Amy Landucci (GSK).

The full article can be read at https://thehealthcaretechnologyreport.com/

About The Healthcare Technology Report

The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.

Share article on social media or email:

TriageLogic Announces SOC 2 Type 2 Certification for Its Nurse Triage Software


A triage nurse reviews secure patient data on her laptop as part of SOC 2 certification.

…TriageLogic has been working diligently to complete [SOC 2 certification], while continuing to offer healthcare providers secure, HIPAA-compliant nurse triage services…

SOC 2 certification represents the highest degree of excellence in data systems and operations control. Certification comes in two stages: an initial audit of a company’s data safeguards and a second audit that occurs at least six months or later to verify these safeguards are operating correctly. TriageLogic, a healthcare organization that specializes in nurse triage, nurse telehealth, and remote patient monitoring (RPM), is proud to be working on the completion of its SOC 2 certification.

The Purpose

SOC 2 isn’t simply a nice-to-have feature in data security. Because ransomware attacks have doubled in the last two years, it’s now an essential component for patient data protection and management. That’s why TriageLogic has been working diligently to complete this process, while continuing to offer healthcare providers secure, HIPAA-compliant nurse triage services and telehealth software for doctors’ offices.

TriageLogic’s Nurse Triage Software

TriageLogic considers SOC 2 certification an essential benchmark for ensuring peace of mind for doctors’ offices and hospital systems when it comes to the management and security of their patient data.That includes TriageLogic’s nurse triage software, MyTriageChecklist, which is available to license to medical organizations directly, or used with TriageLogic’s outsourced service, Nurse Triage On Call. This software provides nurses an intuitive solution for evaluating patient symptoms over the phone. Using the gold-standard of nurse triage protocols developed by Drs. Schmitt and Thompson, nurses can evaluate symptom severity and provide patients with dispositions regarding the most appropriate level of care to seek. This software is available for provider practices, health plans, and hospitals.

According to TriageLogic’s CTO, Dr. Ravi Raheja, “more than ever, the security and safekeeping of protected health information (PHI) have been a concern in healthcare. We are excited to provide an additional layer of security and trust to our clients and partners.”

Benefits of MyTriageChecklist

MyTriageChecklist meets the following criteria for managing patient data and upholding the trust principles of SOC 2 certification:


  • A secure, HIPAA-compliant private cloud.
  • An intuitive user interface.
  • Permits customized orders and paths to care.
  • Ensures consistent, effective care for every patient interaction.
  • Offers compatibility with existing healthcare systems and EMRs.

Demo MyTriageChecklist

TriageLogic recognizes that there isn’t a one-size-fits-all solution to nurse triage. That’s why TriageLogic emphasizes the ability to customize and track changes within proprietary software, while still maintaining standards for HIPAA data compliance. Any healthcare providers that would like to test this software with their own staff are encouraged to contact TriageLogic to schedule a demonstration.

About TriageLogic

TriageLogic is a URAC-accredited, physician-led provider of top-quality nurse telehealth technology, remote patient monitoring, and medical call center service. Founded in 2007, the TriageLogic Group now serves more than 9,000 physicians and covers over 25 million lives nationwide.

Share article on social media or email:

AdaptX Hires Dr. Andrew Foster, MD, COL (USA Retired) as Vice President for Military & Veterans Health


AdaptX, a clinical performance management solution company, is pleased to announce the appointment of Andrew Foster, MD, COL (USA Retired) as Vice President for Military & Veterans Health. AdaptX’s hiring of Dr. Foster in this executive leadership role reflects AdaptX’s commitment to supporting military clinicians in their mission to provide the best possible healthcare to service members, veterans and their families. In his new position, Dr. Foster will be responsible for managing AdaptX’s relationships with the Defense Health Agency (DHA) and the Department of Veterans Affairs (VA).

Prior to his recent retirement from active duty, Dr. Foster served for many years as Chief of Madigan Army Medical Center’s Department of Anesthesia and Operative Services at Joint Base Lewis-McChord. In this leadership role, Dr. Foster supervised treatment for thousands of service members and their families. Long known for his commitment to innovation, Dr. Foster played an integral role in patient safety, EMR (MHS Genesis) implementation, and OR efficiency. Dr. Foster’s innovations in patient safety were recognized by the Army Medical Department’s Patient Safety Program as standard-setting achievements that have been replicated Army-wide.

“AdaptX is honored to benefit from Colonel Foster’s deep expertise in providing military healthcare,” said Warren Ratliff, chief executive officer of AdaptX. “Colonel Foster is not only well-respected physician but also a recognized leader in clinical operations excellence. We are thrilled to have Colonel Foster join AdaptX as we work to support our military medical services in their mission to maintain the health and readiness of our service members serving in harm’s way.”

“I am excited to join AdaptX to support my passion for improving quality and capacity. With our military’s implementation of a new generation of electronic health records, we have a unique opportunity to support our military clinicians and administrators in leveraging their real-world data to improve and manage care,” said Dr. Andrew Foster, vice president for military and veterans health of AdaptX. “AdaptX empowers clinical leaders to monitor and evaluate care across patients, so that clinicians can rapidly adapt care to achieve better quality, efficiency, and equity. I look forward to working with leaders and clinicians from all branches of the military to advance these goals.”

Foster’s leadership role at AdaptX builds on the tremendous success that the company has had in catalyzing transformations in the quality, efficiency, and equity of care. For example, a hospital using AdaptX recently generated an additional 150,000 minutes per year of surgical capacity, dramatically increasing revenue while reducing clinician burnout, without changing staffing. Using the same AdaptX solution, a health system eliminated opioids from more than 40,000 surgery cases. At the same time, another customer used AdaptX to identify and address disparities in maternal health. These case studies and more can be found at adaptx.com/results.

About AdaptX

With AdaptX’s unique Adaptive Clinical Management™ solution, health systems transform clinical performance, delivering dramatically better patient care and financial results. AdaptX’s AI-driven Mission Control Center empowers clinical leaders to quickly and easily leverage their real-world data to visualize performance, compare approaches, and adapt – across patients, teams, protocols, workflows, and facilities.

AdaptX is headquartered in Seattle and was founded in 2016. To learn more, please visit adaptx.com.

Share article on social media or email:

Kayal Orthopaedic Center Has Been Named A 2022 NJ Top Doc Practice


News Image

Kayal Orthopaedic Center is home to an elite team of surgeons and specialists fully committed to skillful, restorative patient care. Each physician is a leader in his or her field, delivering the finest in orthopaedic treatment, sports medicine expertise and musculoskeletal disease management.

A few of the reviewed and approved NJ Top Docs who are a part of this outstanding team include Robert A. Kayal, MD, FAAOS, FAAHKS, Edward C. Friedland, MD, FAAOS, E. Jeffrey Pope, MD, FAAOS, Victor Ortiz-Declet, MD, Edward A. Lin, MD and Amit Sood, MD, FAAOS.

The Kayal team offers the full range of orthopaedic services in one convenient location.

When you require more than one orthopaedic-related service, Kayal Orthopaedic Center’s team members consult with each other to make sure your care is consistent and top-notch. This team’s specialties include orthopaedics, pain & spine, robotic joint replacement, shoulder & elbow, hand & wrist, foot & ankle, hip & knee, hip preservation, podiatry, rheumatology, osteoporosis, osteoarthritis & orthobiologics, sports medicine, chiropractic and laser treatment.

If your injury, chronic condition, recovery or rehabilitation requires physical therapy, you’re also in the very best hands possible under the Kayal Medical Group umbrella. The practice’s physical therapists and chiropractors are highly trained, experienced and committed to the same patient-friendly approach that has always been the hallmark of this practice.

To learn more about the reviewed and approved NJ Top Docs at Kayal Orthopaedic Center, please visit: https://njtopdocs.com/nj-doctors/kayalorthopaedic/

About Us

NJ Top Docs is a comprehensive, trusted and exclusive healthcare resource featuring reviewed and approved Top Doctors and Dentists in New Jersey online in an easy to use format. NJ Top Docs only reviews and approves providers based on merit after they have been extensively vetted.

NJ Top Docs is a division of USA Top Docs which allows patients to meet providers online before making their appointment.

For more information, please click here to contact us or visit http://www.NJTopDocs.com.

You can also follow us on Facebook, Twitter, & Instagram.

Share article on social media or email:



Part 1” is an enjoyable collection of poetic works and narratives based on the author’s faith


News Image

“Celeste’s Creative Writings: Part 1”: an uplifting message of God’s love delivered via vibrant poetry and other personal writings. “Celeste’s Creative Writings: Part 1” is the creation of published author Celeste Boone.

Boone shares, “my creative writings are God-inspired as well as friend-inspired that I have been working on since I’ve been in child care. Being a teacher to babies up to two year olds as well as a Spanish teacher to all ages; I’m always making up stories and songs, some longer than others. Most of my writings do rhyme. Most of my writings are meant to be serious, but there are a few silly writings and songs included. Most of my poems have history and biblical references to them. Of course, there are romantic poems and a fairy-tale story.

“My writings include poetry, songs, and a story. All three categories have both English and Spanish included in them. My creative writings are meant for all ages, male and female, believers and nonbelievers. They’re also for mothers and fathers, grandparents, and children. The poetry part of my book is broken down into four chapters: preaching/sharing the gospel, educational, holiday, and random things that inspired me. The songs are all Christian-based songs. All my writings have some sort of message to them. With four chapters of poems, three chapters of songs, and one chapter with a story, my creative writings are full of wonders that come from the heart and give hope and encouragement.”

Published by Christian Faith Publishing, Celeste Boone’s new book provides readers an enjoyable opportunity for celebrating one’s faith daily.

Boone shares in hopes of spreading a positive message of God’s love through encouraging poems, songs, and so much more.

Consumers can purchase “Celeste’s Creative Writings: Part 1” at traditional brick & mortar bookstores, or online at Amazon.com, Apple iTunes store, or Barnes and Noble.

For additional information or inquiries about “Celeste’s Creative Writings: Part 1,” contact the Christian Faith Publishing media department at 866-554-0919.

Share article on social media or email:

Gene & Cell Therapy Regulation Webinar on August 10, 2022


Gene & Cell Therapy Regulation:

Comparability and Other New Developments

An FDAnews Webinar

Wednesday, Aug. 10, 2022, 1:30 p.m.–3:00 p.m. EDT

https://wcg.swoogo.com/gene-and-cell-therapy-reg

For drugmakers involved in developing gene and cell therapy products, the FDA and other regulators have made it clear: comparability studies are essential to product approval. But if manufacturers don’t have a handle on the new requirements a minor process change could cause enormous issues with quality and efficacy. And compliance.

This webinar will enable attendees to understand and comply with the FDA’s requirements and avoid common errors, so they can maintain their products’ critical quality attributes (CQAs) and bring them to market.

Scott R. Burger, MD, the principal of Advanced Cell & Gene Therapy, and William E. Janssen, PhD, the principal of WEJ Cell and Gene Therapy Consulting Services, will explain exactly what attendees need to know about comparability, including:


  • FDA requirements for comparability studies for gene and cell therapy products
  • Best practices for risk analysis and mitigation using comparability studies
  • How to design an effective comparability protocol for a gene or cell therapy product
  • How to construct a statistical approach to comparability
  • How to assemble the comparability package to comply with FDA requirements
  • An update on FDA regulatory announcements that include forming a consortium to deal with rare diseases and potential guidance about intermediate pathways

Understanding and meeting, comparability requirements is crucial to developing gene and cell therapy products. This is an opportunity for drugmakers to ensure theirs comply.

Webinar Details

Gene & Cell Therapy Regulation:

Comparability and Other New Developments

An FDAnews Webinar

Wednesday, Aug. 10, 2022, 1:30 p.m.–3:00 p.m. EDT

https://wcg.swoogo.com/gene-and-cell-therapy-reg

Tuition:

$287

Easy Ways to Order:

Online: https://wcg.swoogo.com/gene-and-cell-therapy-reg

By phone: 888.838.5578 or 703.538.7600

About FDAnews:

FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews’ print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA’s complex and ever-changing regulations.

Share article on social media or email:

BayMark Announces the Acquisition of San Antonio Recovery Center


No matter what BayMark-owned facility is initially contacted, the BayMark Health Services continuum of care offers options to meet that patient where they are at in their journey toward recovery.

BayMark Health Services has announced the acquisition of San Antonio Recovery Center, a residential treatment company based in San Antonio, TX. For more than 10 years, San Antonio Recovery Center (SARC) has been providing a range of comprehensive programs to treat individuals with substance use disorders including detoxification, residential treatment, partial hospitalization and intensive outpatient programs, as well as ongoing support through aftercare, alumni programs and transitional housing. SARC has two residential facilities, as well as an outpatient program and alumni center in San Antonio.

More than 4,000 Texans died of a drug related overdose in 2021, and many believe those numbers are under-reported.

BayMark, through its various treatment brands, owns and operates 10 facilities in Texas offering medication-assisted treatment and detoxification options for those with opioid use and other substance use disorders, including two opioid treatment programs in San Antonio and an outpatient detoxification unit in nearby Austin, TX. The addition of the SARC programs in San Antonio improves our ability to provide Texans living with a substance use disorder the treatment option that best meets their needs.

David K. White, Ph.D., CEO of BayMark Health Services noted, “No matter what BayMark-owned facility is initially contacted, the BayMark Health Services continuum of care offers options to meet that patient where they are at in their journey toward recovery. It has always been our number one priority to ensure that each patient has access to the right kind of treatment for them, when they need it, be it abstinence-based or with the use of supportive medications. With our growth comes an enhanced ability to fill that need for the patients, families and communities we serve.”

San Antonio Recovery Center focuses on tailoring a treatment program to the unique circumstances of each patient’s substance use disorder. That includes accurate diagnosis of other co-occurring disorders if appropriate. SARC’s residential, PHP and IOP programs use effective strategies to guide patients as they develop reliable stress management strategies, create relationships with others in recovery, discover new interests and ways to spend free time, build self-confidence, work on relationships with family and loved ones, begin focusing on physical health and wellness, and most importantly to develop a thorough aftercare plan.

“We are so impressed by the clinical care provided by the SARC team. They are a welcome addition to the BayMark family as we improve our ability to offer comprehensive treatment options to our patients,” shared Mike Saul, BayMark Health Services Executive Vice President, Operations.

The Braff Group, a leading mergers and acquisitions firm, represented San Antonio Recovery Center in this transaction.

For more information on San Antonio Recovery Center, visit: http://www.SanAntonioRecoveryCenter.com.

About BayMark Health Services:

BayMark Health Services provides Substance Use Disorder and Mental Health treatment services to 73,000+ individuals actively participating in treatment each and every day across more than 400 recovery programs in 36 states and 3 Canadian provinces. The largest provider of Opioid Use Disorder (OUD) services in North America and the leader in comprehensive behavioral health services for SUD’s and Behavioral Disorders, BayMark’s continuum of care includes medication-assisted treatment (MAT), withdrawal management, PHP, IOP, counseling and other innovative and effective therapies in outpatient, inpatient and residential settings.

Share article on social media or email: